Skip to content

CYPH CYPH Investing Cash Flow

Investing Cash Flow at other companies

Pfizer logo
PfizerPFE
$785M-76.0%
Merck & Co. logo
Merck & Co.MRK
-$10.21B-587%
Amgen logo
AmgenAMGN
-$716M-60.2%
MicroStrategy logo
MicroStrategyMSTR
-$7.25B+5.5%
Ziff Davis logo
Ziff DavisZD
-$33.21M+48.8%
Zscaler logo
ZscalerZS
-$418.66M

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-58.2%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Return on equity-108.2%-34.4pp
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Reported directly by CYPH in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's investing cash flow?
CYPH (CYPH) reported investing cash flow of -$9M in Q1 2026.
How has CYPH's investing cash flow changed year-over-year?
CYPH's investing cash flow increased by 62.9% year-over-year, from -$24.25M to -$9M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.